APP and Alzheimer disease: APP/PS1 mice that are deficient in caspase-1 or NLRP3 have been shown to exhibit reduced spatial memory loss, decreased impairment of hippocampal synaptic plasticity, and amelioration of other AD-related symptoms [21,40] (Figure 2).